Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00035906 | Research Study in Patients With Persistent Macular Edema | PHASE2 | COMPLETED | 315 | — | — | Oct 1, 2001 | Aug 1, 2004 | May 30, 2011 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| DEX PS DDS® | DRUG | - |
Inclusion: Persistent macular edema associated with diabetic retinopathy, uveitis, retinal vein occlusion, or Irvine-Gass syndrome, persisting at least 90 days after laser treatment or medical management by a physician. Exclusion: Females who are pregnant or lactating, and females of childbearing p...